HK1222810A1 - 治疗开角型青光眼和高眼压症的药物递送系统和方法 - Google Patents

治疗开角型青光眼和高眼压症的药物递送系统和方法 Download PDF

Info

Publication number
HK1222810A1
HK1222810A1 HK16111148.0A HK16111148A HK1222810A1 HK 1222810 A1 HK1222810 A1 HK 1222810A1 HK 16111148 A HK16111148 A HK 16111148A HK 1222810 A1 HK1222810 A1 HK 1222810A1
Authority
HK
Hong Kong
Prior art keywords
latanoprost
eye
implant
iop
lacrimal
Prior art date
Application number
HK16111148.0A
Other languages
English (en)
Chinese (zh)
Inventor
潘迪克.烏特克赫德
潘迪克.乌特克赫德
蘇珊娜.卡登
苏珊娜.卡登
郝勇
Original Assignee
麦提疗法有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 麦提疗法有限公司 filed Critical 麦提疗法有限公司
Publication of HK1222810A1 publication Critical patent/HK1222810A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
HK16111148.0A 2012-05-03 2013-02-27 治疗开角型青光眼和高眼压症的药物递送系统和方法 HK1222810A1 (zh)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US61/642,287 2012-05-03
US201261644397P 2012-05-08 2012-05-08
US201261644401P 2012-05-08 2012-05-08
US61/644,397 2012-05-08
US61/644,401 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US61/659,921 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US61/680,641 2012-08-07
US201261717615P 2012-10-23 2012-10-23
US61/717,615 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (1)

Publication Number Publication Date
HK1222810A1 true HK1222810A1 (zh) 2017-07-14

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111148.0A HK1222810A1 (zh) 2012-05-03 2013-02-27 治疗开角型青光眼和高眼压症的药物递送系统和方法

Country Status (7)

Country Link
EP (1) EP2844224B1 (cg-RX-API-DMAC7.html)
JP (1) JP6213560B2 (cg-RX-API-DMAC7.html)
CN (1) CN105473130A (cg-RX-API-DMAC7.html)
CA (1) CA2872338C (cg-RX-API-DMAC7.html)
HK (1) HK1222810A1 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN09713A (cg-RX-API-DMAC7.html)
WO (1) WO2013164671A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma
US12544258B2 (en) 2023-01-30 2026-02-10 Jeffrey Whitsett Aqueous micro shunt

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
ES2105333T3 (es) 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
US20040170685A1 (en) 2003-02-26 2004-09-02 Medivas, Llc Bioactive stents and methods for use thereof
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
EP1704141B1 (en) 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
AU2005269988B2 (en) 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
KR20090006153A (ko) 2006-03-31 2009-01-14 큐엘티 플러그 딜리버리, 인코포레이티드 비루관계에 대한 약물 전달 방법, 구조, 및 조성물
CA2674076A1 (en) * 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
JP2010537776A (ja) 2007-09-07 2010-12-09 キューエルティー プラグ デリバリー,インク. 涙管インプラント用の挿入および抜き取り工具
AU2008300013A1 (en) 2007-09-07 2009-03-19 Qlt Inc. Drug cores for sustained release of therapeutic agents
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
BRPI0817082A2 (pt) 2007-09-07 2015-03-31 Qlt Plug Delivery Inc Implantes lacrimais e métodos relacionados
EP2276492A2 (en) * 2008-05-09 2011-01-26 QLT Plug Delivery, Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
BRPI1007318A2 (pt) 2009-01-23 2019-04-09 Qlt Inc. distribuição com liberação sustentada de um ou mais agentes.
CA2752645C (en) * 2009-02-23 2017-10-03 Qlt Inc. Lacrimal implants and related methods
US20120245539A1 (en) 2009-11-27 2012-09-27 Qlt Inc. Lacrimal implants including split and insertable drug core

Also Published As

Publication number Publication date
CA2872338C (en) 2021-09-14
CA2872338A1 (en) 2013-11-07
JP2015520628A (ja) 2015-07-23
EP2844224A4 (en) 2016-02-24
JP6213560B2 (ja) 2017-10-18
EP2844224B1 (en) 2018-04-11
IN2014DN09713A (cg-RX-API-DMAC7.html) 2015-07-31
CN105473130A (zh) 2016-04-06
EP2844224A1 (en) 2015-03-11
WO2013164671A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
US10632012B2 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
EP2389221B1 (en) Sustained released delivery of one or more agents
CA2722971C (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US20090318549A1 (en) Combination treatment of glaucoma
US9974685B2 (en) Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP2015037542A (ja) 鼻涙系用の薬物送達方法、構造および組成物
JP6213560B2 (ja) 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法
HK1158951A (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
HK1162151B (en) Sustained released delivery of one or more agents
HK1156835A (zh) 青光眼的聯合治療